Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARENA: Aspirin to reduce inflammation in human in vivo model of acute lung injury
2012-001589-13Phase 2Unknown
- Sponsor
- Belfast Health and Social Care Trust
- Start
- May 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of aspirin in acute lung injury (ALI) (3 arms), sponsored by Belfast Health and Social Care Trust. Primary endpoint: BAL IL-8 concentration. Status: unknown.
02
Drugs
aspirin
03
Conditions
acute lung injury (ALI)
Beyond the preview
Go deeper on 2012-001589-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001589-13.